期刊
BRITISH JOURNAL OF HAEMATOLOGY
卷 166, 期 1, 页码 34-49出版社
WILEY
DOI: 10.1111/bjh.12878
关键词
Hodgkin; Hodgkin lymphoma; treatment; chemotherapy; radiotherapy
类别
资金
- Cancer Research UK [15556] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0513-10144, NF-SI-0507-10370] Funding Source: researchfish
The guideline group was selected to be representative of UK-based medical experts and patients' representatives. MEDLINE and EMBASE were searched systematically for publications in English from January 1990 to June 2013 using the key words Hodgkin, Lymphoma, Treatment, Chemotherapy and Radiotherapy. References from relevant publications were also searched. The writing group produced the draft guideline, which was subsequently revised by consensus by members of the Haemato-Oncology Task Force of the British Committee for Standards in Haematology (BCSH). The guideline was then reviewed by a sounding board of approximately 50 UK haematologists and the BCSH and comments incorporated where appropriate. The 'GRADE' system was used to quote levels and grades of evidence, details of which can be found in Appendix I. The objective of this guideline is to provide healthcare professionals with clear guidance on the management of patients with classical Hodgkin Lymphoma (HL). The guidance may not be appropriate for all patients with HL and in all cases individual patient circumstances may dictate an alternative approach.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据